Tony Hunter, Brian Druker and John Mendelsohn have won this year’s Tang Prize in biopharmaceutical science for their breakthroughs in developing targeted cancer therapies, the Tang Prize Selection Committee announced yesterday.
Their research and findings of protein tyrosine phosphorylation and tyrosine kinases as oncogenes have led to successful targeted cancer therapies, the committee said.
The three winners, all Americans, have shown how basic science can lead to clinical applications that benefit humankind, said Chang Wen-chang (張文昌), a member of Academia Sinica and the convener of the selection committee.
Hunter demonstrated that a mechanism called tyrosine phosphorylation acts as a master on/off switch for a number of key proteins that are critical for successful cancer therapies, the committee said.
Hunter, a professor of biology at the Salk Institute, gave birth to the field of targeted therapies after discovering in 1979 the mechanism of tyrosine phosphorylation and that the oncogene Src is a tyrosine kinase.
The historic discovery paved the way for active research in the following two decades on tyrosine kinase oncogenes, ultimately leading to the development of tyrosine kinase inhibitors (TKIs).
Based on Hunter’s discovery, Druker, the director of Oregon Health & Science University’s Knight Cancer Institute, led the successful clinical trial of a cancer-fighting drug called imatinib.
The drug turned chronic myelogenous leukemia, a cancer that once had a very low survival rate, into a manageable condition.
Gleevec, a brand of imatinib, shuts off oncogenic signals by inhibiting Abl-protein tyrosine kinases as predicted by Hunter’s original research, the committee said.
Gleevec has also been successfully used in the treatment of acute lymphocytic leukemia and certain types of gastrointestinal stromal tumors by inhibiting other tyrosine kinase oncoproteins.
There are more than 26 TKIs that have been approved for clinical use. All of the discoveries have Druker’s first successful trials to thank because they spurred this still burgeoning targeted therapy era, the committee said.
John Mendelsohn, president emeritus of MD Anderson Cancer Center, took another approach to combating cancer.
An alternative way of shutting off the activities of tyrosine kinases on the cell surface (receptor tyrosine kinase) is to develop antibodies against the extracellular domain of the receptor, the committee said.
In such a way, the natural ligand, or growth factor, can no longer bind and the receptor tyrosine kinase is no longer activated. Mendelsohn and his team came up with the idea that antibodies targeting the epidermal growth factor receptor (EGFR) may be an effective strategy for cancer treatment.
Mendelsohn led his team in conducting preclinical research and proceeded to develop the anti-EGFR antibody cetuximab, which eventually won the US Food and Drug Administration’s approval for the treatment of colon cancer and head/neck cancer.
‘VIRUS DIPLOMACY’: The nation’s expertise in handling COVID-19 was among the reasons that it should not be excluded from the WHO, the European Parliament said The European Parliament this week passed resolutions that support Taiwan’s bid to participate in the WHO and its intention to negotiate a trade pact with Taiwan. During its plenary session from Monday to Thursday, the parliament approved resolutions on the foreign policy consequences of the COVID-19 outbreak and the EU’s trade policy, parts of which were viewed as friendly toward Taiwan by the Ministry of Foreign Affairs. In a statement yesterday, the ministry welcomed the passage of the resolutions and thanked the parliament for its support for Taiwan. In the first resolution, the parliament cited Beijing’s increasing threats to Taiwan, the crackdown on
The gig began with a nun chanting on stage, but suddenly erupted into a wall of noise unleashed by distorted guitars and screamed sutras — the unique sound of Taiwan’s first Buddhist death metal band. The nation has a vibrant metal scene, but few outfits are quite as eye-catching as Dharma (達摩樂隊), a band that aims to deliver enlightenment via the medium of throaty eight-string guitars and guttural roars. Dressed in robes — black, of course — they use traditional Sanskrit sutras as lyrics, but everything else screams death metal, from bloody face paint on stage to growled vocals, relentless riffs and
LOOPHOLES: The people behind biased media content produced by a Chinese network, likely without sending staff to Taiwan, remain anonymous, a source said Beijing’s latest attempt at psychological warfare through heavily biased online media is aimed at sowing discord and polarizing Taiwanese society, the Mainland Affairs Council (MAC) said. The council’s comment came in response to Chinese network Southeast Television, which late last month began broadcasting an online program featuring commentary by Taiwanese unification supporters that authorities suspect was filmed illegally in Taiwan. To circumvent cross-strait regulations, the broadcaster collaborated with online service provider Baidu to air the series titles Diverse Voices From the Taiwan Strait (台海百家說). Only Taiwanese are shown on camera, without revealing the host, interviewer or production team. In one video, political commentator and
SUPPRESSION: Michael Tsai, a former defense minister, said that Beijing’s list of Taiwan independence advocates contravenes the UN’s Universal Declaration of Human Rights The best way to respond to threats from China against Taiwan independence advocates is for the president to publicly reiterate Taiwan’s sovereignty, former minister of national defense Michael Tsai (蔡明憲) said on Sunday. Chinese media on Nov. 15 said that the Chinese Communist Party (CCP) was compiling “a list of stubborn Taiwanese separatists and will severely punish them in accordance with [China’s] Anti-Secession Law and hold them accountable for their actions for the rest of their lives.” Chinese media subsequently accused Premier Su Tseng-chang (蘇貞昌) of being a “first-rate war criminal,” because of his policy on mask exports. “The vast majority